Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

NewSelf vs StaveMD

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
NewSelf logo

NewSelf

8.3
★★★★☆4.2/5

Best for: lowest-cost compounded GLP-1 with pharmacy quality transparency

Visit NewSelf →
VS
StaveMD logo

StaveMD

7.1
★★★★☆3.6/5

Best for: people who want semaglutide, tirzepatide, an oral tablet or a microdose from one brand, billed monthly

Visit StaveMD →

NewSelf and StaveMD are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, NewSelf starts lower at $100/mo versus $149/mo, and NewSelf edges ahead overall (8.3 vs 7.1 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

NewSelf

Semaglutide+ (best price)Compounded
$100/mo
semaglutide

All dosages same price

Semaglutide+ (regular)Compounded
$135/mo
semaglutide
Tirzepatide+ (best price)Compounded
$144/mo
tirzepatide

All dosages same price

Tirzepatide+ (regular)Compounded
$225/mo
tirzepatide

StaveMD

Injection, month-to-month (4-week plan, billed every 4 weeks)Compounded
$149/mo
semaglutide

12 weeks $417, 24 weeks $774, 52 weeks $1,417 upfront (the "$109/mo" headline)

Oral dissolving tablet, month-to-month (4-week plan, billed every 4 weeks)Compounded
$199/mo
semaglutide

12 weeks $567, 24 weeks $1,074, 52 weeks $2,197 upfront (the "$169/mo" headline)

Injection, month-to-month (4-week plan, billed every 4 weeks)Compounded
$199/mo
tirzepatide

12 weeks $567, 24 weeks $1,074, 52 weeks $2,067 upfront (the "$159/mo" headline)

Microdose injection, month-to-month (4-week plan, billed every 4 weeks)Compounded
$179/mo
semaglutide

12 weeks $477, 24 weeks $894, 52 weeks $1,677 upfront (the "$129/mo" headline)

Microdose injection, month-to-month (4-week plan, billed every 4 weeks)Compounded
$179/mo
tirzepatide

Same ladder as semaglutide microdose: 12 weeks $477, 24 weeks $894, 52 weeks $1,677

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 520+ providers' prices on their own sites and email you when tracked prices move.

What’s included

NewSelf

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

StaveMD

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

NewSelf

8.3/10

Overall

StaveMD

7.1/10

Value25%

9.0A
vs
B
7.5

Effectiveness25%

8.0A
vs
B
8.0

User Experience15%

8.0A
vs
B
6.5

Trust & Safety15%

8.3A
vs
B
6.0

Accessibility10%

8.5A
vs
B
7.5

Support10%

7.9A
vs
B
6.0

Features & Coverage

FeatureNewSelfStaveMD
Starting Price✓$100/mo$149/mo
Features6 features✓8 features
States Available49Not disclosed
Compounded✓ Yes✓ Yes
Brand Name——
FSA/HSA Accepted—✓ Yes
FDA Warnings1 warning✓None

About NewSelf

NewSelf offers compounded semaglutide+ (with B12/Glycine, from $99.97/mo) and compounded tirzepatide+ (with B6/Glycine, from $144.49/mo). LegitScript certified. Available in 48 states + Puerto Rico. Uses 503A licensed pharmacies with third-party testing.

Read our full NewSelf review →

About StaveMD

StaveMD is a telehealth brand that prescribes compounded semaglutide (injection or dissolving tablet), tirzepatide and low-dose microdose programs through OpenLoop's clinician network, with named compounding pharmacies and free shipping. Month-to-month plans start at $149 for semaglutide and $199 for tirzepatide. The "from $109/mo" headline is the 52-week plan, charged as $1,417 upfront.

Read our full StaveMD review →

Pros & Cons

NewSelf

What we like

  • Semaglutide+ from $99.97/mo — among the lowest prices in the dataset
  • All dosages at the same price — no price escalation as dose increases
  • LegitScript certified with 503A licensed pharmacies
  • Third-party potency, sterility, and endotoxicity testing
  • 48 states + Puerto Rico coverage
  • B12/B6 + Glycine enhanced formulations
  • No membership fees

Watch-outs

  • Not available in Mississippi and Louisiana
  • Compounded only — no brand-name options
  • Site also promotes AI health optimization and longevity (broader platform)

StaveMD

What we like

  • Month-to-month semaglutide injections at $149 per 4 weeks, with no membership fee on top
  • Offers injections, a daily dissolving semaglutide tablet, and low-dose microdose programs for semaglutide or tirzepatide
  • Names its prescribing group (OpenLoop Healthcare Partners) and four fulfilling pharmacies, with addresses, in its terms
  • Cancel any time from your account, with no phone call and no notice period
  • Full refund if a provider decides treatment isn't right for you, since no medication is ordered
  • Free shipping, and the site says plans are HSA/FSA eligible

Watch-outs

  • The "from $109/mo" headline is the 52-week plan, charged as $1,417 upfront; month-to-month semaglutide is $149
  • Plans are labeled "/mo" but bill every 4 weeks, which is 13 charges a year, not 12
  • The full price list only appears after the whole health intake and your name, address, phone and email
  • "Trusted by millions" and "2,000,003+ members" are OpenLoop network totals, not StaveMD patients, per its own footer
  • The homepage says "LegitScript-certified," but no certification record exists for the site in LegitScript's directory
  • Refundability of unused months on a prepaid 12, 24 or 52-week plan is not spelled out
  • Support is email-only; no phone number is published

Our Verdict

Winner: NewSelf

NewSelf edges out StaveMD with a higher overall score of 8.3/10 and is particularly strong for lowest-cost compounded GLP-1 with pharmacy quality transparency. StaveMD remains a solid alternative, especially if you're looking for people who want semaglutide, tirzepatide, an oral tablet or a microdose from one brand, billed monthly.

Choose NewSelf if…

You want lowest-cost compounded GLP-1 with pharmacy quality transparency and a starting price around $100/mo.

Choose StaveMD if…

You want people who want semaglutide, tirzepatide, an oral tablet or a microdose from one brand, billed monthly and a starting price around $149/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.2

Willow

Mainstream telehealth GLP-1 access

7.2

Fella Health

Men's weight loss

7.3

Sunlight

Compounded GLP-1 with unlimited telehealth visits and free shipping

NewSelf vs StaveMD: FAQ

NewSelf is cheaper. Its lowest ongoing monthly cash price is $100/mo, compared with $149/mo for StaveMD. We compare standing (not first-month promo) prices so the figures reflect what you'd actually pay month to month.
NewSelf scores higher overall at 8.3/10 versus 7.1/10, and is particularly strong for lowest-cost compounded GLP-1 with pharmacy quality transparency. That said, StaveMD is a better fit if you want people who want semaglutide, tirzepatide, an oral tablet or a microdose from one brand, billed monthly.
NewSelf lists availability in 49 states, while StaveMD's state list is not publicly listed.
Neither NewSelf nor StaveMD is currently an affiliate partner, so we earn no commission from either. We rank all providers editorially using the same six-dimension framework and disclose any commercial relationships.
For Semaglutide, NewSelf is cheaper at $100/mo versus $149/mo at StaveMD.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring NewSelf and StaveMD head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.